Selected research
Market Outlook & Growth Opportunities
Global DNA Microinjection Services Market Outlook and Growth Opportunities 2026
Market perspective
The global DNA Microinjection Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for DNA Microinjection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for DNA Microinjection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for DNA Microinjection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the DNA Microinjection Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the DNA Microinjection Services market include Charles River, PolyGene, Taconic Biosciences, GenOway, Applied StemCell, JAX Mice, Biomodels, ModelOrg and Cyagen Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global DNA Microinjection Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of DNA Microinjection Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents DNA Microinjection Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA Microinjection Services market.
DNA Microinjection Services Segment by Company
Charles River
PolyGene
Taconic Biosciences
GenOway
Applied StemCell
JAX Mice
Biomodels
ModelOrg
Cyagen Biosciences
Biocytogen
GemPharmatech
Nanjing Aibei Biotechnology
Nanjing Senbega Biotechnology
Hangzhou Baiti Biotechnology
DNA Microinjection Services Segment by Type
Pronuclear Injection
Cytoplasmic Injection
Blastocyst Injection
Others
DNA Microinjection Services Segment by Application
Biomedicine
Agriculture & Animal Husbandry
Others
DNA Microinjection Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global DNA Microinjection Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the DNA Microinjection Services key companies, revenue, market share, and recent developments.
3. To split the DNA Microinjection Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions DNA Microinjection Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify DNA Microinjection Services significant trends, drivers, influence factors in global and regions.
6. To analyze DNA Microinjection Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Microinjection Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Microinjection Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Microinjection Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Microinjection Services industry.
Chapter 3: Detailed analysis of DNA Microinjection Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of DNA Microinjection Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of DNA Microinjection Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Pronuclear Injection
- Cytoplasmic Injection
- Blastocyst Injection
- Others
Applications
- Biomedicine
- Agriculture & Animal Husbandry
- Others
Companies covered
- Charles River
- PolyGene
- Taconic Biosciences
- GenOway
- Applied StemCell
- JAX Mice
- Biomodels
- ModelOrg
- Cyagen Biosciences
- Biocytogen
- GemPharmatech
- Nanjing Aibei Biotechnology
- Nanjing Senbega Biotechnology
- Hangzhou Baiti Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global DNA Microinjection Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global DNA Microinjection Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 DNA Microinjection Services Market Dynamics
- 2.1 DNA Microinjection Services Industry Trends
- 2.2 DNA Microinjection Services Industry Drivers
- 2.3 DNA Microinjection Services Industry Opportunities and Challenges
- 2.4 DNA Microinjection Services Industry Restraints
3 DNA Microinjection Services Market by Company
- 3.1 Global DNA Microinjection Services Company Revenue Ranking in 2025
- 3.2 Global DNA Microinjection Services Revenue by Company (2021-2026)
- 3.3 Global DNA Microinjection Services Company Ranking (2024-2026)
- 3.4 Global DNA Microinjection Services Company Manufacturing Base and Headquarters
- 3.5 Global DNA Microinjection Services Company Product Type and Application
- 3.6 Global DNA Microinjection Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global DNA Microinjection Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 DNA Microinjection Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 DNA Microinjection Services Market by Type
- 4.1 DNA Microinjection Services Type Introduction
- 4.1.1 Pronuclear Injection
- 4.1.2 Cytoplasmic Injection
- 4.1.3 Blastocyst Injection
- 4.1.4 Others
- 4.2 Global DNA Microinjection Services Sales Value by Type
- 4.2.1 Global DNA Microinjection Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global DNA Microinjection Services Sales Value by Type (2021-2032)
- 4.2.3 Global DNA Microinjection Services Sales Value Share by Type (2021-2032)
5 DNA Microinjection Services Market by Application
- 5.1 DNA Microinjection Services Application Introduction
- 5.1.1 Biomedicine
- 5.1.2 Agriculture & Animal Husbandry
- 5.1.3 Others
- 5.2 Global DNA Microinjection Services Sales Value by Application
- 5.2.1 Global DNA Microinjection Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global DNA Microinjection Services Sales Value by Application (2021-2032)
- 5.2.3 Global DNA Microinjection Services Sales Value Share by Application (2021-2032)
6 DNA Microinjection Services Regional Value Analysis
- 6.1 Global DNA Microinjection Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global DNA Microinjection Services Sales Value by Region (2021-2032)
- 6.2.1 Global DNA Microinjection Services Sales Value by Region: 2021-2026
- 6.2.2 Global DNA Microinjection Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America DNA Microinjection Services Sales Value (2021-2032)
- 6.3.2 North America DNA Microinjection Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe DNA Microinjection Services Sales Value (2021-2032)
- 6.4.2 Europe DNA Microinjection Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific DNA Microinjection Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific DNA Microinjection Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America DNA Microinjection Services Sales Value (2021-2032)
- 6.6.2 South America DNA Microinjection Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa DNA Microinjection Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa DNA Microinjection Services Sales Value Share by Country, 2025 VS 2032
7 DNA Microinjection Services Country-level Value Analysis
- 7.1 Global DNA Microinjection Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global DNA Microinjection Services Sales Value by Country (2021-2032)
- 7.2.1 Global DNA Microinjection Services Sales Value by Country (2021-2026)
- 7.2.2 Global DNA Microinjection Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt DNA Microinjection Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt DNA Microinjection Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt DNA Microinjection Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Charles River
- 8.1.1 Charles River Company Information
- 8.1.2 Charles River Business Overview
- 8.1.3 Charles River DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Charles River DNA Microinjection Services Product Portfolio
- 8.1.5 Charles River Recent Developments
- 8.2 PolyGene
- 8.2.1 PolyGene Company Information
- 8.2.2 PolyGene Business Overview
- 8.2.3 PolyGene DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.2.4 PolyGene DNA Microinjection Services Product Portfolio
- 8.2.5 PolyGene Recent Developments
- 8.3 Taconic Biosciences
- 8.3.1 Taconic Biosciences Company Information
- 8.3.2 Taconic Biosciences Business Overview
- 8.3.3 Taconic Biosciences DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Taconic Biosciences DNA Microinjection Services Product Portfolio
- 8.3.5 Taconic Biosciences Recent Developments
- 8.4 GenOway
- 8.4.1 GenOway Company Information
- 8.4.2 GenOway Business Overview
- 8.4.3 GenOway DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.4.4 GenOway DNA Microinjection Services Product Portfolio
- 8.4.5 GenOway Recent Developments
- 8.5 Applied StemCell
- 8.5.1 Applied StemCell Company Information
- 8.5.2 Applied StemCell Business Overview
- 8.5.3 Applied StemCell DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Applied StemCell DNA Microinjection Services Product Portfolio
- 8.5.5 Applied StemCell Recent Developments
- 8.6 JAX Mice
- 8.6.1 JAX Mice Company Information
- 8.6.2 JAX Mice Business Overview
- 8.6.3 JAX Mice DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.6.4 JAX Mice DNA Microinjection Services Product Portfolio
- 8.6.5 JAX Mice Recent Developments
- 8.7 Biomodels
- 8.7.1 Biomodels Company Information
- 8.7.2 Biomodels Business Overview
- 8.7.3 Biomodels DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Biomodels DNA Microinjection Services Product Portfolio
- 8.7.5 Biomodels Recent Developments
- 8.8 ModelOrg
- 8.8.1 ModelOrg Company Information
- 8.8.2 ModelOrg Business Overview
- 8.8.3 ModelOrg DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.8.4 ModelOrg DNA Microinjection Services Product Portfolio
- 8.8.5 ModelOrg Recent Developments
- 8.9 Cyagen Biosciences
- 8.9.1 Cyagen Biosciences Company Information
- 8.9.2 Cyagen Biosciences Business Overview
- 8.9.3 Cyagen Biosciences DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Cyagen Biosciences DNA Microinjection Services Product Portfolio
- 8.9.5 Cyagen Biosciences Recent Developments
- 8.10 Biocytogen
- 8.10.1 Biocytogen Company Information
- 8.10.2 Biocytogen Business Overview
- 8.10.3 Biocytogen DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Biocytogen DNA Microinjection Services Product Portfolio
- 8.10.5 Biocytogen Recent Developments
- 8.11 GemPharmatech
- 8.11.1 GemPharmatech Company Information
- 8.11.2 GemPharmatech Business Overview
- 8.11.3 GemPharmatech DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.11.4 GemPharmatech DNA Microinjection Services Product Portfolio
- 8.11.5 GemPharmatech Recent Developments
- 8.12 Nanjing Aibei Biotechnology
- 8.12.1 Nanjing Aibei Biotechnology Company Information
- 8.12.2 Nanjing Aibei Biotechnology Business Overview
- 8.12.3 Nanjing Aibei Biotechnology DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.12.4 Nanjing Aibei Biotechnology DNA Microinjection Services Product Portfolio
- 8.12.5 Nanjing Aibei Biotechnology Recent Developments
- 8.13 Nanjing Senbega Biotechnology
- 8.13.1 Nanjing Senbega Biotechnology Company Information
- 8.13.2 Nanjing Senbega Biotechnology Business Overview
- 8.13.3 Nanjing Senbega Biotechnology DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Nanjing Senbega Biotechnology DNA Microinjection Services Product Portfolio
- 8.13.5 Nanjing Senbega Biotechnology Recent Developments
- 8.14 Hangzhou Baiti Biotechnology
- 8.14.1 Hangzhou Baiti Biotechnology Company Information
- 8.14.2 Hangzhou Baiti Biotechnology Business Overview
- 8.14.3 Hangzhou Baiti Biotechnology DNA Microinjection Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Hangzhou Baiti Biotechnology DNA Microinjection Services Product Portfolio
- 8.14.5 Hangzhou Baiti Biotechnology Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst